WAVE Life Sciences (WVE) Misses Q1 EPS by 22c

WAVE Life Sciences (NASDAQ: WVE) reported Q1 EPS of ($0.27), $0.22 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $12.9 million versus the consensus estimate of $38.6 million.

For earnings history and earnings-related data on WAVE Life Sciences (WVE) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• RBC initiates GE HealthCare as it sees AI-led innovation cycle driving growth
• Nike names former Pfizer CFO David Denton as new finance chief